Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research
Published in: Breast Cancer Research 2/2008

01-05-2008 | Poster presentation

From association to cause: fine mapping of the TNRC9gene region, a novel susceptibility locus identified in the first genome-wide association study for breast cancer

Authors: S Ahmed, M Maranian, CS Gregory, M Udler, HI Field, J Tyrer, R Hesketh, JC Metcalfe, S Scollen, JP Stuewing, BAJ Ponder, PDP Pharoah, DF Easton, AM Dunning

Published in: Breast Cancer Research | Special Issue 2/2008

Login to get access

Excerpt

We identified five novel breast cancer susceptibility loci in a recent Genome Wide Association Study [1] using 227,876 single nucleotide polymorphisms (SNPs) and up to 50,000 female breast cancer cases and controls from 22 studies. …
Literature
1.
Easton DF, et al: Genome Wide Association Study identifies a novel breast cancer susceptibility loci. Nature. 2007, 447: 1087-1093. 10.1038/nature05887.CrossRefPubMedPubMedCentral
2.
Stacey SN, et al: Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer. Nat Genet. 2007, 39: 865-869. 10.1038/ng2064.CrossRefPubMed
Metadata
Title
From association to cause: fine mapping of the TNRC9gene region, a novel susceptibility locus identified in the first genome-wide association study for breast cancer
Authors
S Ahmed
M Maranian
CS Gregory
M Udler
HI Field
J Tyrer
R Hesketh
JC Metcalfe
S Scollen
JP Stuewing
BAJ Ponder
PDP Pharoah
DF Easton
AM Dunning
Publication date
01-05-2008
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue Special Issue 2/2008
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr1933

Other articles of this Special Issue 2/2008

Breast Cancer Research 2/2008 Go to the issue

Poster presentation

Investigation of immunoregulatory mechanisms relating to poor surgical wound healing and breast cancer recurrence

Oral presentation

Loss of oestrogen receptor alpha in long-term antioestrogen-resistant cells: reversal by a c-src inhibitor

Poster presentation

Proapoptotic protein Bid is regulated by phosphorylation during anoikis and the cell cycle

Poster presentation

Topoisomerase II expression as a determinant of chromosomal radiosensitivity and possible susceptibility in breast cancer

Poster presentation

De novo expression of αvβ6 integrin by myoepithelial cells in ductal carcinoma in situ may be an important marker of disease progression

Poster presentation

Zinc transporter HKE4 as a new target in antihormone resistance of breast cancer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits